Sign up to save your podcasts
Or
Share 【日】ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
【日】ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.
JAMA Otolaryngol Head Neck Surg. 2025 May 22:e250903.掲載
「ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.」
概要の英語での読み上げ音声です。
#HPV陽性中咽頭がん
#中咽頭がん
#補助療法
#再発リスク
View all episodes
By 株式会社メディカルレビュー社JAMA Otolaryngol Head Neck Surg. 2025 May 22:e250903.掲載
「ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical Trial.」
概要の英語での読み上げ音声です。
#HPV陽性中咽頭がん
#中咽頭がん
#補助療法
#再発リスク